Results of non-medical switching from original infliximab to its Russian biosimilar in patients with ulcerative colitis
Aim. To evaluate the efficacy and safety of the Russian biosimilar infliximab in patients with ulcerative colitis (UC). Materials and methods. This is a retrospective study of stable patients with UC, who are followed up at the department of bowel pathology of Loginov Moscow Clinical Scientific C...
Saved in:
| Main Authors: | Maria I. Timanovskaia, Oleg V. Knyzev, Asfold I. Parfenov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
"Consilium Medicum" Publishing house
2025-01-01
|
| Series: | Терапевтический архив |
| Subjects: | |
| Online Access: | https://ter-arkhiv.ru/0040-3660/article/viewFile/646287/193077 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predictors of infliximab efficacy in patients with severe attack of ulcerative colitis
by: A. O. Golovenko, et al.
Published: (2013-10-01) -
How We Can Personalize the Infliximab Use in Ulcerative Patients
by: Mohammed Hussien Ahmed, et al.
Published: (2025-06-01) -
Case Report: Hemolytic anemia secondary to infliximab treatment in a patient with ulcerative colitis
by: Gerolamo Bevivino, et al.
Published: (2025-03-01) -
Comparative efficacy and safety of infliximab biosimilar (BCD-055) and innovator infliximab in patients with ankylosing spondylitis (results of international, multiple-center, double-blind phase I and phase III clinical studies)
by: D. E. Karateev, et al.
Published: (2017-09-01) -
Case Presentation: a Facial Ulceration in a Patient with Ulcerative Colitis
by: Andreea GHIDERSA, et al.
Published: (2020-09-01)